Skip directly to content

Train – Pitch- Meet - Training and Selection of Europe’s best Biotech Startups - International Biotech Semifinal of the European Health Catapult

on 12. Oktober 2017 - 15:11

On October 4-6, BioRN, together with EIT Health, organized the Biotech Semifinal of the European Health Catapult. The Biotech semifinal consisted of two training days on October 4/5 at the Hotel Villa Toscana in Leimen|Heidelberg and one competition day on October 6 at the Studio Villa Bosch in Heidelberg.

13 innovative start-up teams from all over Europe (9 countries) were participating: Affichem, Elthera AG, EVEXyS, LifeTag, Lumobiotics, Microbrain Biotech, Nanoligent, NoMicro, Peptomyc, SpyBiotech, SUN Bioscience, Prelife, Vitroscan.

The aim of the training days was to mentor and prepare the start-up teams in the topics of e.g. Drug Development and Regulatory Affairs, Business Plan Development, Financing, Marketing and Market Access, Negotiation and Intellectual Property (IP). 9 Experienced coaches and mentors/experts of different expertise coming from the healthcare industry or investment sector were passionate to advise the startups in intense one on one sessions during the two training days. The spirit during the semifinal was very supportive. The vivid exchange with peers and mentors generated an atmosphere of entrepreneurial spirit and support.

In addition, the start-ups were intensively prepared for their 5-min pitch presentation in front of the jury on October 6th. A professional pitch trainer was working intensively with the entrepreneurs on their presentation skills and pitch decks.

During the competition day on October 6 at the Studio Villa Bosch in Heidelberg, the 13 start-ups presented their innovative technologies and businesses in enthusiastic 5-minute live pitches. Renowned jury members with healthcare and biotech technology backgrounds, selected the 7 best Biotech start-ups in the European Health Catapult competition that will enter the next stage, the final during the EIT Health Summit in London on 4-5 December.

Around 60 participants including healthcare professionals and investors from the Venture Capital, Crowdinvestment, Business Angels and Family Office were participating in the event. In one on one meetings interested investors, leading healthcare professionals could meet up with the startups to discuss potential collaboration, investment or partnerships.

The selected 7 Finalists are (alphabetical order):

  • Affichem: Development of Dendrogenins for the prevention/treatment of deafness.
  • Elthera AG: Development of an antibody against the cancer treatment target L1CAM
  • LifeTag: Diagnostic solutions to detect chronic metabolic diseases.
  • Lumobiotics: Photoswitchable anticancer & antimicrobial peptide drugs.
  • Peptomyc: Myc inhibitor protein with cell penetrating properties for cancer treatment
  • SpyBiotech: Bacterial superglue technology to generate vaccines more quickly
  • SUN Bioscience: organoid culture platform for personalized treatment (cystic fibrosis)

The 7 finalists have now the chance to win prizes of: First prize 20.000 Euro, Second prize 15.000 Euro and third prize 10.000 Euro in the Biotech Category.

Medical Valley EMN together with Cap Digital is managing the European Health Catapult programme as part of the EIT Health Accelerator

Kommentieren Sie diesen Beitrag und diskutieren Sie mit anderen Akteuren in der Medical Valley-Community auf Xing.
Wir freuen uns auf Sie!

Addthis